Down-regulation of BIRC3 can enhance the drug sensitivity of 5-FU in oral squamous cell carcinoma, esophageal adenocarcinoma and other malignant tumors in later studies [38, 39]. This evidence concerns the gene BIRC3 and oral cavity squamous cell carcinoma.